KFAR SABA, Israel, Oct. 15, 2019 /PRNewswire/ -- CartiHeal, developer of Agili-C™, a proprietary implant for the treatment of cartilage lesions in arthritic and non-arthritic joints, announced today the first implantation of the Agili-C™ implant, as part of Investigati...

New WhiteSource for Developers integrations with GitLab Core and Eclipse IDE empower even more enterprise developers to create secure products faster.

Read more

Based in Rehovot, the medical device company has developed a proprietary 355nm wavelength laser technology platform.

US medical device company AngioDynamics Inc. (NASDAQ: ANGO) today announced an agreement to acquire Israel laser technology developer Eximo Medical Ltd....

A typical lettings agent could save some two and a half hours’ time each working day if they adopted more Artificial Intelligence to take over routine tasks. 

That’s the view of virtual assistant Roby.ai which says its time saving estimate is conservative if agents all...

TEL AVIV, Israel, May 23, 2019 /PRNewswire/ -- WhiteSource, the leader in open source security and license compliance management, announced today a partnership with GitHub, the leading software development platform, to help developers more easily detect open...

תחרות על עובדים מוכשרים בענף ההייטק גוברת. במסגרת סדרת הראיונות של ערוץ הייטקיסט עם מנהלים בארגונים, מצאו אנשי "כלכליסט" כי עבור טאלנטים, הבחירה במקום העבודה הבא מבוססת על הרבה מעבר לתלוש השכר. ראיון עם  יונתן שניר, מנכ״ל ומייסד שותף בחברת קליקלאפ.

קראו ע...

TEHOVOT, Israel--(BUSINESS WIRE)--Eximo Medical Ltd., announced today the successful launch and first commercial use of the B-Laser™ Atherectomy System for treatment of peripheral vascular disease. Dr. Barry Weinstock of Orlando Heart & Vascular Institute, director of...

TEL AVIV, Israel, Oct. 17, 2018 /PRNewswire/ — WhiteSource, the leader in continuous open source security management, announced a $35 million funding round led by Susquehanna Growth Equity, with participation by existing investors 83North and M12 – Microsoft Ventures....

Israel cardiovascular device developer Cardiovalve said yesterday it launched both the Ahead US and Ahead EU multicenter studies of its Cardiovalve transfemoral mitral valve replacement system. Read more